PCOS patient PCOS , Metabolic syndrome, insulin resistance
Conditions
Interventions
PCOS patient with non metabolic syndrome confirm by blood test ,PCOS patient with metabolic syndrome confirm by blood test
Prevention,Prevention
group 1,group 2
Sponsors
Faculty of Medicine, Thammasat University
pending
Eligibility
Sex/Gender
Female
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: participants attending the gynecology clinic will be recruited during the study period.
Exclusion criteria
Exclusion criteria: Women who have received hormonal medications affecting serum androgen levels, including anti-androgen drugs or oral contraceptive pills, within 3 months prior to study enrollment. Women currently taking antihypertensive medications. Women currently using lipid-lowering medications. Women currently taking insulin-sensitizing agents or glucose-lowering medications due to elevated blood glucose levels. Women diagnosed with hirsutism and/or insulin resistance due to other causes, including congenital adrenal hyperplasia (CAH), Cushing's syndrome, hypothyroidism, or adrenal gland tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of insulin resistance among women diagnosed with PCOS. at study enrollment Insulin resistance will be assessed using the Homeostatic Model Assessment of Insulin Resistance (HOMA-IR) calculated from fasting plasma glucose and fasting insulin levels. | — |
Secondary
| Measure | Time frame |
|---|---|
| Prevalence of metabolic syndrome among women with PCOS. At study enrollment Metabolic syndrome will be diagnosed according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) criteria. | — |
Countries
Thailand
Contacts
Public ContactAwatif Umar
Department of Obstetrics and Gynecology, Faculty of Medicine, Thammasat University
Outcome results
None listed